Indegene Ltd Total Liabilities

Latest as of March 2026: Rs14.82 Billion INR ≈ $160.23 Million USD

Indegene Ltd total liabilities. Based on the latest financial reports, Indegene Ltd (INDGN) has total liabilities worth Rs14.82 Billion INR (≈ $160.23 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Indegene Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Indegene Ltd (2020–2026)

Total liabilities of Indegene Ltd from 2020 to 2026. This chart illustrates how Indegene Ltd's total liabilities have evolved over time, based on quarterly financial data.

Indegene Ltd Competitors by Total Liabilities

The table below lists competitors of Indegene Ltd ranked by their total liabilities.

Company Country Total Liabilities
Bayer Cropscience Limited
NSE:BAYERCROP
India Rs-29.66 Billion
GS Engineering & Construction
KO:006360
Korea ₩12.66 Trillion
Live Oak Bancshares, Inc.
NYSE:LOB
USA $14.72 Billion
Vietnam National Petroleum Group
VN:PLX
Vietnam ₫77.19 Trillion
Compania Nationala de Transport al Energiei Electrice Transelectrica SA
RO:TEL
Romania RON4.14 Billion
Harbin Boshi Automation Co Ltd
SHE:002698
China CN¥2.93 Billion
Telecom Argentina
BA:TECO2
Argentina AR$9.64 Trillion
Golden Ocean Group Ltd
NASDAQ:GOGL
USA $1.57 Billion

Liability Composition Analysis (2020–2026)

This chart breaks down Indegene Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see INDGN total assets.

Liquidity & Leverage Metrics

Indegene Ltd Total Liabilities Ratios Explained

Indegene Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.41 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.47 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Indegene Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Indegene Ltd (2020–2026)

The table below shows the annual total liabilities of Indegene Ltd from 2020 to 2026.

Year Total Liabilities Change
2026-03-31 Rs14.82 Billion
≈ $160.23 Million
+108.59%
2025-03-31 Rs7.10 Billion
≈ $76.82 Million
-36.38%
2024-03-31 Rs11.16 Billion
≈ $120.75 Million
-2.07%
2023-03-31 Rs11.40 Billion
≈ $123.30 Million
+93.39%
2022-03-31 Rs5.90 Billion
≈ $63.76 Million
+124.21%
2021-03-31 Rs2.63 Billion
≈ $28.44 Million
-57.30%
2020-03-31 Rs6.16 Billion
≈ $66.60 Million
--

About Indegene Ltd

NSE:INDGN India Health Information Services
Market Cap
$1.59 Billion
Rs147.27 Billion INR
Market Cap Rank
#6736 Global
#319 in India
Share Price
Rs612.80
Change (1 day)
-1.07%
52-Week Range
Rs423.50 - Rs619.40
All Time High
Rs732.70
About

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more